Efficacy and safety of trifluridine/tipiracil treatment in patients with metastatic gastric cancer who had undergone gastrectomy: subgroup analyses of a randomized clinical trial
Authors
Ilson, DHTabernero, J
Prokharau, A
Arkenau, HT
Ghidini, M
Fujitani, K
Van, CE
Thuss-Patience, P
Beretta, GD
Mansoor, Was
Zhavrid, E
Alsina, M
George, B
Catenacci, D
McGuigan, S
Makris, L
Doi, T
Shitara, K
Affiliation
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New YorkIssue Date
2019
Metadata
Show full item recordCitation
Ilson DH, Tabernero J, Prokharau A, Arkenau HT, Ghidini M, Fujitani K, et al. Efficacy and safety of trifluridine/tipiracil treatment in patients with metastatic gastric cancer who had undergone gastrectomy: subgroup analyses of a randomized clinical trial. JAMA Oncol. 2019.Journal
JAMA OncologyDOI
10.1001/jamaoncol.2019.3531PubMed ID
31600365Additional Links
https://dx.doi.org/10.1001/jamaoncol.2019.3531Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1001/jamaoncol.2019.3531
Scopus Count
Collections
Related articles
- Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.
- Authors: Mansoor W, Arkenau HT, Alsina M, Shitara K, Thuss-Patience P, Cuffe S, Dvorkin M, Park D, Ando T, Van Den Eynde M, Beretta GD, Zaniboni A, Doi T, Tabernero J, Ilson DH, Makris L, Benhadji KA, Van Cutsem E
- Issue date: 2021 Jul
- Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial.
- Authors: Shitara K, Doi T, Dvorkin M, Mansoor W, Arkenau HT, Prokharau A, Alsina M, Ghidini M, Faustino C, Gorbunova V, Zhavrid E, Nishikawa K, Hosokawa A, Yalçın Ş, Fujitani K, Beretta GD, Cutsem EV, Winkler RE, Makris L, Ilson DH, Tabernero J
- Issue date: 2018 Nov
- Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials.
- Authors: Yoshino T, Cleary JM, Van Cutsem E, Mayer RJ, Ohtsu A, Shinozaki E, Falcone A, Yamazaki K, Nishina T, Garcia-Carbonero R, Komatsu Y, Baba H, Argilés G, Tsuji A, Sobrero A, Yamaguchi K, Peeters M, Muro K, Zaniboni A, Sugimoto N, Shimada Y, Tsuji Y, Hochster HS, Moriwaki T, Tran B, Esaki T, Hamada C, Tanase T, Benedetti F, Makris L, Yamashita F, Lenz HJ
- Issue date: 2020 Jan
- Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancer.
- Authors: Mayer RJ, Hochster HS, Cohen SJ, Winkler R, Makris L, Grothey A
- Issue date: 2018 Dec
- Pharmacokinetics, Safety, and Preliminary Efficacy of Oral Trifluridine/Tipiracil in Chinese Patients with Solid Tumors: A Phase 1b, Open-Label Study.
- Authors: Wang X, Zhou J, Li Y, Ge Y, Zhou Y, Bai C, Shen L
- Issue date: 2020